Hormone Replacement Therapy After Risk-Reducing Surgery in Individuals at Increased Risk for Breast Cancer: The Patient Perspective
Survey for individuals with a BRCA1, BRCA2, PALB2, RAD51C, RAD51D mutation
About the Study
NOTE: This study is no longer recruiting people.
In this study, we aim to better understand patient perceptions about hormone replacement therapy () and identify factors informing decision making about for use in individuals who have a , , , or genetic mutation that increases breast and ovarian cancer risk.
Individuals who have undergone risk-reducing surgery for ovarian cancer will be asked to complete a survey about their thoughts, experiences and understanding of the risks and benefits related to hormone replacement therapy.
This Study is Open To:
NOTE: This study is no longer recruiting people.
This Study is NOT Open To:
NOTE: This study is no longer recruiting people.
Survey for individuals with a BRCA1, BRCA2, PALB2, RAD51C, RAD51D mutation